PARG and neoplasm: Lastly, consistent with PARG involvement in SSBR, it was reported recently [16] that depletion of PARG activity, using either siRNA or the reported PARG inhibitor Gallotannin, in tumour cells deficient in the homologous recombination repair pathway resulted in selective sensitisation.